Abstract: For the treatment of severe symptomatic aortic valve stenosis, minimally invasive heart valve prostheses are increasingly used, especially for elderly patients. The current generation of devices is based on xenogenic leaflet material, involving limitations with regard to calcification and durability. Artificial polymeric leaflet-structures represent a promising approach for improvement of valve performance. Within the current work, finite-element analysis (FEA) design studies of polymeric leaflet structures were conducted. Design of an unpressurized and axiallysymmetric trileaflet heart valve was developed based on nine parameters. Physiological pressurization in FEA was specified, based on in vitro hydrodynamic testing of a commercially available heart valve prosthesis. Hyperelastic constitutive law for polymeric leaflet material was implemented based on experimental stress strain curves resulting from uniaxial tensile and planar shear testing. As a result of FEA, time dependent leaflet deformation of the leaflet structure was calculated. Obtained leaflet dynamics were comparable to in vitro performance of the analyzed prosthesis. As a major design parameter, the lunula angle has demonstrated crucial influence on the performance of the polymeric leaflet structures. FEA represented a useful tool for design of improved polymeric leaflet structures for minimally invasive implantable heart valve prostheses.
Introduction
Heart valves are passive components to regulate the blood flow into and out of the heart. Opening and closing of heart valves in vivo is induced by a gradient of blood pressure between the in-and outflow section, respectively. During a lifetime, native heart valve leaflets pass through more than a billion cycles of opening and closing.
Since the first-in-man implantation in 2002, minimally invasive aortic valve prostheses were increasingly used in clinical practice. In particular, high-risk patients benefit from this therapy. The major limitation of the current generation of devices based on xenogenic leaflet materials is the tendency to calcification and resulting durability issues. Therefore, current research focusses on the development of artificial leaflet structures for minimally invasive implantable heart valve prostheses. Experimental approaches to the use of polymeric materials for surgically or minimally invasive implantable heart valve prostheses have been described in the literature, previously [1, 2] .
Finite-element analysis (FEA) represents an essential tool for design development of heart valve leaflet structures. The influence of various design parameters on the leaflet performance has been investigated in structural mechanical FEA, previously [3] [4] [5] . Within the current work, we used FEA parametric studies for the design of a novel polymeric leaflet-structure for transcatheter heart valves. Influence of lunula angle as a major design parameter on leaflet deformation, leaflet opening area and leaflet coaptation surface area was analyzed.
Materials and methods

Design of leaflet-structures
Axially-symmetric trileaflet heart valve geometry was developed, using computer-aided design (CAD) software Creo Parametric 3.0 (Parametric Technology Corp., Needham, MA, USA). Previously published literature on leaflet geometry was taken into account for design development [5] [6] [7] . Modelling of the leaflet structures was conducted in an unpressurized and closed configuration as a stress-free state. One leaflet was designed by parameters as summarized in Table 1 and placed three times, rotated by 120° around the centre of the valve, respectively. Figure 1 and Figure 2 illustrate the design parameters of the trileaflet heart valve model. 
Finite-element analysis
FEA was used for simulation of valve opening and closing during two complete cardiac cycles of 0.854 s, respectively. Boundary conditions for physiological pressurization were based on ventricular and aortal pressure recordings from in vitro hydrodynamic testing of a commercially available heart valve prosthesis. Hydrodynamic testing was conducted according to ISO 5840-3 Annex N, using a pulse duplicator system (ViVitro Labs, Inc., Victoria, BC, Canada) and a high speed camera system (Optronis CR600x2, Optronis GmbH, Kehl, Germany). For fixation, displacement of commissure was constrained. Surface-to-surface contact was applied between neighboured leaflets using a friction coefficient of 0.3. Hyperelastic constitutive law based on uniaxial tension and planar shear tests was used to describe polymeric material properties. Casted films of polycarbonate based silicone elastomer (Chronosil 80A, AdvanSource Biomaterials Corp., Wilmington, MA, USA) were analyzed in 0.9% NaCl solution at 37°C, using a universal testing machine Zwick/Roell Z2.5/TN (Zwick GmbH & Co. KG, Ulm, Germany). A generalized isotropic Ogden model with a density of 10 -9 kg/mm³ and a poisson ratio of 0.475 was defined.
Meshing was conducted, using a total of 20,000 C3D8 continuum elements and a global edge length of 0.20 μm. ABAQUS/Explicit 6.14-5 (Dassault Systèmes, Vélizy-Villacoublay, France) was used for FEA. 
Leaflet deformation
Leaflet deformation during one cardiac cycle of 0.854 s was characterized by seven significant points in time within the phase of exertion, expulsion, leaflet closure and refilling. Leaflet performance during one cardiac cycle is illustrated exemplary for a heart valve model with a lunula angle of 35° (see Figure 3) . For a lunula angle of 0° a characteristic twisting of leaflets was observed during diastole leading to enhanced leaflet closing and tightening. With increasing lunula angle the twisting of leaflets decreased. Thus, lunula angle has a crucial influence on leaflet closure.
Leaflet motion in FEA corresponds well to in vitro hydrodynamic and high speed camera analysis of a commercially available heart valve prosthesis (data not shown). Boundary conditions based on pressure recordings from in vitro hydrodynamic testing enable realistic and physiological heart valve motion in FEA. 
Leaflet opening area
The characteristic leaflet opening area (LOA) represents a projection of the flow cross-section into a plane perpendicular to flow direction. LOA was analysed during opening and closing in the second cardiac cycle (see Figure 4) .
Depending on the lunula angle, considerable differences in LOA were identified. Maximum LOA for each lunula angle is summarized in Table 2 . With an increasing lunula angle, LOA increased likewise. Therefore, in terms of a maximized flow cross-section, a high lunula angle is preferable. 
Leaflet coaptation surface area
The leaflet coaptation surface areas (CSA) of three contact pairs in a heart valve model were combined to an average CSA, respectively. Figure 5 shows the average CSA for heart valve models with lunula angles ranging from 0° to 50° during the second cardiac cycle. Minor contact between neighboured leaflets occurred during systole (87 ms ≤ t ≤ 365 ms). During diastole (365 ms ≤ t ≤ 854 ms) CSA increased rapidly and equilibrated at a relatively constant level. Maximum CSA for each lunula angle is summarized in Table 3 . CSA magnitude decreased with an increasing lunula angle. Therefore, in terms of leaflet closing and tightening, a low lunula angle is preferable. 
Conclusion
Within the current study, we obtained time dependent deformation of polymeric leaflet-structures of heart valve prosthesis depending on the lunula angle. Assessment of CSA between neighboured leaflets and LOA demonstrated a crucial influence of lunula angle on the performance of polymeric leaflet-structures. An increase of lunula angle leads to an increased LOA while the leaflet CSA decreases, simultaneously. Therefore, the choice of a specific lunula angle influences flow cross-section (depending on LOA) and closing behaviour (depending on CSA). Definition of boundary conditions based on in vitro hydrodynamic and high speed camera analysis of a commercially available heart valve prosthesis yields physiological motion of leaflets in FEA. Therefore, FEA represented a useful tool for design of improved polymeric leaflet structures for minimally invasive implantable heart valve prostheses. 
